Please login to the form below
HIV therapy
This page shows the latest HIV therapy news and features for those working in and with pharma, biotech and healthcare.
AbbVie’s HIV therapy Kaletra fails to show efficacy in COVID-19
Drug failed to improved condition of hospitalised COVID-19 patients. AbbVie’s HIV combination treatment Kaletra has failed to improve the condition of patients hospitalised with COVID-19, a British study ... Although AbbVie has failed to repurpose its
Latest news
-
Trump calls on FDA to cut ‘red tape’ as coronavirus drug trials gather pace
There was disappointing news after a clinical trial of AbbVie’s HIV therapy Kaletra (lopinavir/ritonavir) – conducted by doctors in China in 199 severely-ill COVID-19 patients – found no benefit ... Earlier this week, Johnson &Johnson also said
-
Gilead drug reduces HIV viral reservoir, says researcher
Years ago, it was proposed that aggressive ART regimens might be able to eliminate HIV entirely, but subsequent research showed that there are reservoirs of dormant virus protected from drug therapy ... Stem cell transplants are high-risk procedures, so
-
FDA rejects ViiV’s long-acting monthly HIV injection
The combination treatment was touted by ViiV as a next-generation HIV therapy, due to the fact that it could free people with the virus from taking daily oral pills. ... Three patients treated with ViiV’s injectable (1%) demonstrated a failure to
-
NIH, Gates pledge $200m for HIV and sickle cell gene therapies
for sickle cell disease (SCD) and HIV that will be available for patients in lower-income countries. ... person infected with HIV by mimicking a rare form of natural immunity to the virus.
-
J&J pledges $500m investment into HIV and tuberculosis R&D
Using this investment, J&J has said it will continue to advance various investigational vaccine regimes to help prevent HIV. ... J&J is also partnered with GlaxoSmithKline subsidiary ViiV Healthcare on a long-acting injectable two-drug regimen for the
More from news
Approximately 2 fully matching, plus 78 partially matching documents found.
Latest Intelligence
-
Choices, choices: the rapidly evolving HIV treatment landscape
This type of combination therapy is known as highly active antiretroviral therapy (HAART), and remains the recommended treatment for HIV today. ... Ipsos' HIV Therapy Monitor data shows that the top reason for prescribing an STR is convenience.
-
Top of the charts
Client:University of Liverpool. Agency:eMedFusion, a division of the KP360 Group. Campaign:HIV iCharts. ... HIV iCharts was launched with great success at the 10th International Congress on Drug Therapy in HIV Infection in November 2010, reaching number
More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.
Latest appointments
-
emotive boosts its client services team
Fay Lepley also joins the agency as an account executive and has had experience working in PR and healthcare communications across several therapy areas including cardiovascular, diabetes and HIV. ... Completing the new team line-up, Sabrina Mohamed has
-
GSK's Deborah Waterhouse to take over from ViiV' Dominique Limet
GlaxoSmithKline has promoted Deborah Waterhouse to replace ViiV Healthcare's CEO Dominique Limet when he steps down from the HIV-focused firm at the end of March. ... I have had the pleasure to work with an exceptional team and am proud of how the
More from appointments
Approximately 0 fully matching, plus 2 partially matching documents found.
Latest from PMHub
-
emotive takes Gold and Silver at PM Society Digital Awards 2018!
innovation. emotive used an innovative technology platform in a live meetings setting to engage an audience of top HIV clinicians. ... Commenting on the news, Senior Account Director and HIV lead for emotive, Andrew Parry, said, “The team at emotive
-
emotive. expands client services team
as an Account Manager. A Biology graduate from the University of Leeds, Rob has experience working in infectious diseases, rare diseases and medical devices, amongst other therapy areas. ... HIV. . Lizzie Nayman, Client Services Director for emotive.
-
A fast-growing client services team at emotive.
Fay has previous experience working in PR and healthcare communications across a number of therapy areas, including cardiovascular, diabetes and HIV. ... Also with a Biomedical Science degree, Sabrina worked in healthcare public relations, specifically
-
Marketing strategy in complex environments
Whilst not new, this approach is becoming increasingly effective for certain therapy areas, particularly oncology. ... Another popular combination therapy is HAART: Highly Active Antiretroviral Therapy used for HIV where six major types of drugs
-
Infographic: HIV Market Snapshot
Our latest HIV infographic, taken from data collected from syndicated tracking study Therapy Watch, reveals that more than 3 in 5 naive or switch patients are currently treated with a STR ... Therapy Watch HIV patient data is collected bi-monthly from
More from PMHub
Approximately 1 fully matching, plus 6 partially matching documents found.
COVID-19 Updates and Daily News
Featured jobs
-
Medical Editor
-
Competitive
-
Healthcare Lead Copywriter
-
Competitive
-
Healthcare Senior Account Manager
-
Competitive
- Account Manager Healthcare / Pharmaceutical Sector
-
Negotiable Salary
- Sales Director, Healthcare communications agency, London/ SE UK
-
Six figure salary
-
Healthcare Account Director
-
Competitive
- GSK’s PD-1 inhibitor dostarlimab shows updated promise in dMMR solid tumours
- Moderna cooperating with investigation into possible COVID-19 vaccine allergic reactions
- Valneva set to begin commercial manufacturing of COVID-19 vaccine within days
- Sinovac’s COVID-19 vaccine appears safe in older adults
- Pfizer introduces new logo in a ‘shift from commerce to science’
- New study identifies drugs that are safe to use in COVID-19 treatment
- Mistrust in medical research: a patient perspective
- Real-world evidence: breaking boundaries in rare disease
- Live Webinar: Importance of Highlighting Patient Voices, Workforce Well-Being, and Health Literacy During and After the Pandemic
- The heavy toll of COVID-19 on cancer patients
- Unpacking rare diseases in the first edition of Delta magazine
- Virtual HealthTech conference powered by Impetus Digital: A Customer Story
PMHub
Aptus Health
Aptus Health is dedicated to advancing health engagement. The company offers end-to-end digital health engagement solutions spanning all areas of...
Latest intelligence
- Mistrust in medical research: a patient perspective
- The recent development of several COVID-19 vaccines has placed medical research firmly in the spotlight, highlighting public confusion and misinformation about clinical trials. Patient advocate, Trishna Bharadia reveals what the...
- Real-world evidence: breaking boundaries in rare disease
- Generating data for drug launches is a challenging process. In rare diseases, with small patient populations and high unmet need, evidence generation is even more complex. Consultant Sarah Poole and...
- The heavy toll of COVID-19 on cancer patients
- We all know that finding and treating cancer early saves lives. During the COVID-19 pandemic, oncology treatments paused while cancer continued to spread. So, what has been the impact of...
Quick links
Infographics
